Notice of Funding Opportunity CDC-RFA-DD23-2301 Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network

Key Dates:

Informational call: July 21, 2022

Optional letter of intent due: July 29, 2022

Deadline to submit questions (via addm@cdc.gov): August 12, 2022

Applications due: September 9, 2022

To view the entire announcement, click here.

Description

This Notice of Funding Opportunity (NOFO) will fund recipient organizations to participate in the Autism and Developmental Disabilities Monitoring (ADDM) Network. The ADDM Network is a population-based, multiple source, records-based surveillance system for autism spectrum disorder (ASD). The goals of the ADDM Network are to

  • Provide estimates of the prevalence and characteristics of children with ASD,
  • Monitor disparities by race/ethnicity and socioeconomic status,
  • Provide data to inform planning for resource and service needs, and
  • Foster activities to increase ASD awareness and reduce barriers to ASD identification.
Informational Call for Potential Applicants

CDC-RFA-DD23-2301

Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network

Thursday, July 21, 2022
1–2 p.m. Eastern

Microsoft Teams

Join on your computer or mobile app

Click here to join the meetingexternal icon

Or call in (audio only)

+1 404-498-3000,,716698762#   United States, Atlanta

(888) 994-4478,,716698762#   United States (Toll-free)

Phone Conference ID: 716 698 762#

Funding will be offered through two components. Component A (required) will focus on conducting surveillance activities to estimate ASD prevalence among 4-year-old and 8-year-old children. Component B (optional) will focus on conducting a surveillance snapshot among 16-year-old children with ASD.  ASD cases will be identified using specific International Classification of Diseases (ICD) codes, eligibilities, or diagnoses in health and education records only. The data elements include

  • Information from comprehensive evaluations,
  • ASD tests,
  • Intelligence quotient (IQ) and adaptive tests,
  • Individual education plans (IEPs),
  • Individualized family service plans (IFSPs), and
  • Other services.

Recipients will also be required to conduct education and community outreach activities, which may include presentations, reports, and publications.

Component A activities include

  • Defining a surveillance area,
  • Establishing agreements for access to BOTH health and education data sources (electronic and/or paper records),
  • Using standardized ADDM Network methodology to conduct surveillance among 4- and 8-year-old children to estimate the prevalence of ASD,
  • Training staff and conducting data quality assurance,
  • Reporting clean, de-identified data with vital records/census linkages to CDC (as part of public health surveillance),
  • Using ADDM Network data to conduct community education and outreach activities, and
  • Conducting evaluation and performance measurement activities.

Component B activities include

  • Defining the same surveillance area as used in Component A,
  • Establishing agreements for access to BOTH health and education data sources (electronic and/or paper records),
  • Using standardized ADDM Network methodology to conduct a surveillance snapshot,
  • Training staff and conducting data quality assurance,
  • Reporting clean, de-identified data with vital records/census linkages to CDC (as part of public health surveillance),
  • Piloting data linkages to post-high school exit outcomes, and
  • Conducting evaluation and performance measurement activities.

Memorandum of Understanding between the State Agency under the Individuals with Disabilities Act (IDEA) and the State Autism Developmental Disabilities Monitoring Program (State ADDM) [94 KB, 6 Pages, 508]

Technical Assistance
For programmatic technical assistance, contact:

Anita Washington, Project Officer, Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities

E-mail: addm@cdc.gov

Phone: 770-488-4104

For assistance submitting the application at www.grants.gov, call the Contact Center at 800-518-4726.

Frequently Asked Questions

Please see below for all Q&As related to this NOFO. This section will be updated on an ongoing basis as new questions are received.

The deadline to submit questions (via addm@cdc.gov) is August 12, 2022.

*The questions published on this web page appear as submitted by the applicants. Typos and inaccuracies may be present.  Please reference the answers for accurate information.

Programmatic Information

Question 1: Is the surveillance area requirement, 12,000-15,000 total children of 4 years of age + 12,000-15,000 total children of 8 years of age + 12,000-15,000 total children of 16 years of age (if we wanted to apply for Component B)? The total would be a minimum of 48,000 children and youth?

Answer 1:  No. The surveillance area for 4-year-olds and 8-year-olds must be the same. The minimum census population estimate for this area is 24,000 children (12,000 4-year-olds and 12,000 eight-year-olds). The surveillance area for Component B must be the same as Component A. Applicants should describe demographics and population estimates for 16-year-olds in this area. We do not specify a minimum population size for the 16-year-old activity.

Question 2: There was a mention that the memorandum of understanding (MOU) template would be provided on the ADDM Network web page, but I could not locate it. Could you please provide a sample?

Answer 2: The memorandum of understanding (MOU) template is available here [94 KB, 6 Pages, 508].

Question 3: Will a select list of ICD codes be provided to aid in the identification of cases for surveillance?

Answer 3: Yes. This list will be provided to the funded recipients.

Question 4: In the Notice of Funding Opportunity (NOFO) it states, “In order to gain access to health records, the recipient organization should have the ability to access personally identifiable health data under a Health Insurance Portability and Accountability Act (HIPAA) exemption (e.g., be a state or local health department or be designated as a bona fide agent of the health department).” We have already accessed HIPAA-related health data during the past four years and have MOUs/memorandum of agreement (MOAs) from relevant source data. Given that there are only three months available to complete the proposal, it seems potentially impossible to get a MOU/MOA from the state health department within this time frame. We did receive a letter designating us as a public health authority for the previous funding cycle, which extends through the end of 2022. Would that letter be applicable for this award?

Answer 4: No. To be responsive to this NOFO, an applicant must provide documentation that they will have access to personally identifiable health records for the period of the new award (January 1, 2023–December 31, 2026). This access could come as a result of being a designated agent to access health records on behalf of the state health department, or by making MOUs/MOAs with individual data sources.

Question 5: For the Federal Information Processing Standards (FIPS) codes, if they are limited to specific census tracts within a county, would that just be the GEOID (consists of the FIPS code + census tract number)?

Answer 5: Yes. Please use the state FIPS code plus the census tract code. To find more information about census tracts please click here.

Question 6: Can we use the funding to incentivize participation by sites of data sources?

Answer 6: No. ADDM Network funding cannot be used to incentivize participation by sites of data sources.

Question 7: Pennsylvania is working on an application for the CDC ADDM Network. In our discussions with the Pennsylvania Department of Education, we are seeking clarification whether school districts participating in CDC ADDM activities could be identified after data collection. Specifically, if data for a child is collected from School District A and submitted to the CDC for ADDM Network activities, will School District A be identifiable?

Answer 7: No. CDC receives only de-identified data; no geographical information smaller than a state will be sent to CDC.

Question 8: Is CDC interested in collecting data in rural areas?  If so, are the minimum population numbers reduced for rural entities?

Answer 8: CDC is interested in collecting data in rural areas. Any proposed study area must meet the minimum population requirements. A rural area might need to be geographically larger to meet population requirements. (refer to Strategy 1 – Activity 1: Define a surveillance area, page 6).

Question 9: For Strategy 2, Activity 11, do you want us to talk about our previous experience or should we propose indicators in this proposal?

Answer 9: Refer to page 10. Applicants will participate in a multisite working group to plan and evaluate approaches to linking education data on children with ASD to Part B Indicator data (Part B Indicator Part B Indicator Measurement Table (PDF) (ed.gov)) and Vocational Rehabilitation services data. Applicants should describe their ability to participate in such a group and describe any previous experience working with or accessing these types of data sources.

Question 10: For Activity 11 (page 10), Is the linkage between education and Vocational Rehab expected to be for both study year cohorts?

Answer 10: The linkages will be discussed and finalized in the working group that will be established with funded recipients.

Question 11: I’m checking to confirm my understanding of the page limit on the Project Narrative for the DD23-2301 application. If a site is applying for only Component A, the page limit is 15 + 4 = 19 pages; and if a site is applying for both Components A and B, the page limit is 15 + 4 + 4 = 23 pages.  Is this correct?

Answer 11: No. Refer to page 29, “10. Project Narrative.” The additional four pages are allotted for applicants who apply for Component B. If the applicant is only applying for Component A, then they are permitted only 15 pages for their application. If the applicant is applying for Components A and B, then they are permitted only 19 pages for their application. The work plan is included in the 15-page limit (Component A) and 19-page limit (Components A and B). All information listed in section H. Other Information is required for this NOFO.

Question 12: I did not see mention collecting data for children with suspected ASD in the NOFO for DD23-2301. Does that mean that data will not be collected on 4-year-olds with Suspected ASD diagnoses in this cycle?

Answer 12: Refer to page 7, “Activity 3 (A3): Use standardized ADDM Network methodology to conduct surveillance among 4- and 8-year-old children to estimate the prevalence of ASD.”  Specific details regarding the surveillance methods will be discussed with the recipients at the beginning of the funding cycle.

Application Information

Question 1: We identified the following discrepancy in the application instructions. Can you please give guidance on which method would be preferred for submitted agreement documentation?

Page 12:

  • Applicants must file the MOU or MOA, as appropriate, name the file “MOUs/MOAs,” and upload it as a PDF file at grants.gov.

Page 19:

  • Applicants must name the attachments “Health_1,” “Health_2,” etc., “Education_1,” “Education_2,” etc.; “Early Intervention_1,” “Early Intervention_2,” etc.; Medicaid_1,” “Medicaid_2,” etc., and upload them as PDF files under “Other Attachment Forms” at grants.gov.

Answer 1: We will accept either style of file names from page 12 or page 19.

Question 2: On behalf of the City of Laredo Health Department, we are conducting our research on the requirements for the grant opportunity CDC-RFA-DD23-2301 Autism Spectrum Disorder 93.998. We will like to engage in the conference call that will be provided on July 21. We would like to request the conference call link to register on time.

Answer 2: Registration is not required for the conference call. The CDC program will hold an informational conference call for potential applicants to ask questions on Thursday, July 21, 2022, at 1 p.m. Eastern. For instructions on how to join and more information on this funding opportunity, please visit the ADDM Network FY23 Funding Opportunity webpage.

Question 3: Our non-profit operates across six states. Is it possible or advisable to propose an application with multiple surveillance areas?

Answer 3: No, a multistate surveillance area cannot be proposed for this application (e.g., Strategy 1 – Activity 1: Define a surveillance area, page 6).

Question 4: Should applicants use the MOU at the URL below as a ‘template’ for our project partners?  Memorandum of Understanding between the State Agency under the Individuals with Disabilities Act (IDEA) and the State Autism Developmental Disabilities Monitoring Program (State ADDM) (cdc.gov)

Answer 4: The MOU/MOA template pertains to educational data sources only.  In order to gain access to education records, the recipient organization must establish a MOU/MOA with education entities (e.g., state department of education and/or individual school districts) that house data on the target age population within the recipient’s designated surveillance area. Agreements made with education organizations must include language that clearly designates the applicant as a designated agent of the education source and will have the ability to access personally identifiable education records. Applicants are encouraged to use the MOU template that establishes the requirements needed to meet the Family Educational Rights and Privacy Act (FERPA) exemption requirements and gain this designation. The template is located on the Autism and Developmental Disabilities Monitoring (ADDM) Network | CDC web page.

Question 5: We are also asking of any assistance in helping to fill out the required paperwork.

Answer 5: CDC will hold an informational conference call for potential applicants to ask questions on Thursday, July 21, 2022, at 1 p.m. Eastern.  Applicants can access the latest information related to the call here.

Question 6: In past ADDM RFPs we had to submit site-specific studies and we aren’t seeing that in this RFP. Is that correct?

Answer 6: Site-specific studies are not included in this NOFO.

Question 7: The RFP says the study area has to be made up of contiguous counties. Is that correct?

Answer 7: Refer to page 6. Surveillance areas must be defined by census tract(s) or county(s) and must be contiguous regions that contain between 12,000 (suggested minimum) – 25,000 (strongly recommended maximum) for 4-year-old children and between 12,000 (suggested minimum) – 25,000 (strongly recommended maximum) for 8-year-old children.

Question 8: Does the CDC allow postdocs or graduate students to be funded from this?

Answer 8: Yes. Activities for all proposed staff should be described in the application and must fall within the program objectives.

Question 9: How do we confirm that we meet the population requirement? Any specific data to submit?

Answer 9: The most accurate source of population data is the U.S. Census Bureau.

Question 10: Census does not breakdown by these specific ages, what do you recommend?

Answer 10: Summary population estimates for the proposed area (total number of 4-and 8-year-old children, and by sex, and race/ethnicity) should be given using (U.S. Census Populations With Bridged Race Categories (cdc.gov)) for counties and American Community Survey Data (census.gov) for census tracts (estimated using 5-year- age groups).

Question 11: Are MOUs with local/county health departments enough or do we need an MOU with the state public health department?

Answer 11: MOU/MOAs with local health departments are sufficient if these entities have authority over access to personally identifiable health information for your proposed surveillance area.

Question 12: On page 19, please elaborate on the IT requirements.

Answer 12: Applicants must demonstrate that they have adequate technical and facility resources to meet the project’s goals, including informational technology (IT) infrastructure to utilize and maintain a Research Electronic Data Capture (REDCap) database and support a SAS license for basic programming. Applicants should have the ability to

  • Manage raw data from health sources and education sources including formatting data into CDC-specified formats for upload and management by the ADDM Information System (composed of REDCap, SAS, and R programs)
  • Configure CDC-provided SAS/R programs to run locally (such as configuring local network locations of editing credentials to access data via Application Programming Interface (API))
  • Understand and use record linkage software (CDC currently uses SAS-callable linkage program that is integrated into the rest of the ADDM Network data management workflow

Question 13: Can you shed some light on the final step which is reporting the data? Is that in 2026?

Answer 13: Refer to page 8. Sites will be required to complete all data collection and related activities within the timeframe specified by CDC (typically within 18 months from the start of the surveillance year (e.g., surveillance year 2022, January 2, 2023–June 30, 2024). Sites are required to report data to CDC typically within 60 days of the end of the surveillance year (e.g., August 2024).

Question 14: Activity 2. Can you give more information on establishing agreements to access Medicaid data?

Answer 14: Refer to page 7. Establishing access to Medicaid data is encouraged but not required.

Question 15: I recently saw and read the announcement about autism prevalence. I’m encouraged to apply both parts (A&B) as it is related to my dissertation study objective. The research model would be cross-sectional only for A, which is the objective of the study as such (not experimental). Do I can apply?

Answer 15: The ADDM Network NOFO is an open competition. This announcement is only for non-research activities supported by the CDC.  If research is proposed, the application will not be considered (please page 1 “C. Announcement Type”.  Please refer to page 23 for the applicant eligibility categories.  All surveillance activities will be cross-sectional in design.

Additional Information on Eligibility (page 24)

Bona fide agents are eligible to apply.  For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located here. The following list of documents are required in the application to be deemed responsive:

  • MOU/MOA with at least one health source or a letter of support indicating that the applicant will have access to personally identifiable health data
  • MOU/MOA with at least one educational source of letter of support indicating that the applicant will have access to personally identifiable educational data

If any of these required documents are missing, the application will be deemed nonresponsive and will not be passed along for further review.

Question 16: Our application will address Component A (4-8-year-olds). Are the additional 4 pages referenced below allotted only for applications that also include Component B (16-year-olds), or are other subsections considered unique to this RFA?

Is the Work Plan included in the 15-page limit, or does it also add 4 pages to the total?

“Multi-component NOFOs may have a maximum of 15 pages for the “base” (subsections of the Project Description that the components share with each other, which may include target population, inclusion, collaboration, etc.); and up to 4 additional pages per component for Project Narrative subsections that are specific to each component.”

Answer 16:  Refer to page 29, “10. Project Narrative.” The additional four pages are allotted for applicants who apply for Component B. If the applicant is only applying for Component A, then they are permitted only 15 pages for their application. If the applicant is applying for Components A and B, then they are permitted only 19 pages for their application. The work plan is included in the 15-page limit (Component A) and 19-page limit (Components A and B).

Question 17: We have a question about the MOU/MOA requirement for health sources.  Our site has had permission for sentinel surveillance of autism to access health records in our surveillance area, including access to PHI. Would that meet the requirement of documenting access to personally identifiable health data, or should we also be seeking individual MOUs from health sources?

Answer 17: Refer to page 12, “b. With organizations not funded by CDC:”

ADDM Network methodology requires access to individual, personally identifiable health and education records.

(required) In order to gain access to health records, the recipient organization should have the ability to access personally identifiable health data under a Health Insurance Portability and Accountability Act (HIPAA) exemption (e.g., be a state or local health department or be designated as a bona fide agent of the health department). Applicants must provide documentation that establishes this designation. In addition, applicants should provide MOU/MOA or letters of support detailing that they will have access to the necessary data, including individual-level PII for purposes of ADDM surveillance from healthcare sources (e.g., healthcare providers or hospital systems) that house data on the target age population within the recipient’s designated surveillance area.

Question 18: In reading through the NOFO, I did not notice if appendices are allowed for additional documentation (outside of MOUs), for example a list of FIPS codes. Is this allowable or does the listings of FIPS codes need to be within the body of the Project Narrative?

Answer 18: Please include the listings of FIPS codes within the body of the Project Narrative. Refer to page 6, “Activity 1(A1): Define a surveillance area.” Applicants must describe their proposed surveillance area. Surveillance areas must be defined by census tract(s) or county(ies) and must be contiguous regions that contain between 12,000 (suggested minimum)–25,000 (strongly recommended maximum) for 4-year-old children and between 12,000 (suggested minimum)–25,000 (strongly recommended maximum) for 8-year-old children. The surveillance area should not be defined by school district or ZIP code as these geographies do not always correspond with census tract(s). The surveillance area description should include a list of the county names with Federal Information Processing Standards (FIPS) codes if the surveillance area is defined by county, or FIPS codes if limiting to specific census tracts within a county. The description should also include summary population estimates for the proposed area (e.g., total number of 4- and 8-year-old children, age, sex, and race/ethnicity).

Question 19: We are hoping you can help clarify something in the RFP language. Are we required to have an MOU/MOA with at least one health source and at least one educational source in order for our proposal to be reviewed? We are asking because of the following language:

On p. 8 it says “Applicants should specify which data sources have already agreed to participate in the project (as evidenced with a signed letter of support (LOS) or memorandum of understanding/memorandum of agreement (MOU/MOA)) and which sources have not yet been approached or have not yet agreed to participate.”

On p. 13 it says “However, for the application, applicants only need to provide one signed MOU/MOA from a health source and one from an education source; these sources need not cover the entire proposed surveillance area. If the applicant is funded, they will then be required to provide documentation of agreements that cover the entire surveillance area.”

On p. 25 it says about scoring “To what extent does the applicant provide documentation to access health records: MOU/MOA for the entire surveillance area (5 points) or MOU/MOA for part of the surveillance area (4 points) OR other documentation (e.g., letter of support) (3 points)”

On p. 13 it sounds like an MOU/MOA from at least one of each type of data source is required, but on the other pages it sounds like with an MOU/MOU or letters of support are sufficient.

Answer 19: Yes, refer to page 24, “2. Additional Information on Eligibility.” The following list of documents are required in the application to be deemed responsive:

  • MOU/MOA with at least one health source or a letter of support indicating that the applicant will have access to personally identifiable health data
  • MOU/MOA with at least one educational source or a letter of support indicating that the applicant will have access to personally identifiable educational data

If any of these required documents is missing, the application will be deemed non-responsive and will not be passed along for further review (e.g., Phase II–objective review panel).

Question 20: On page 12, section b it states that for access to health records “applicants should provide MOU/MOA or letters of support detailing that they will have access to the necessary data”; however, for education records, “the recipient organization must establish a MOU/MOA with education entities.” Does this mean that a letter of support from an education entity would not meet the requirements at the application stage?

Answer 20: A letter of support from an education entity meets responsiveness criteria if it indicates that the applicant will have access to personally identifiable educational data.

Please see page 24 “Additional Information on Eligibility.”

The following documents are required in the application to be deemed responsive:

  • MOU/MOA with at least one health source or a letter of support indicating that the applicant will have access to personally identifiable health data
  • MOU/MOA with at least one educational source or a letter of support indicating that the applicant will have access to personally identifiable educational data

Question 21: In the letters of support/MOU/MOA, do we need to indicate the years from which data will be accessed (e.g., an 8-year-old in surveillance year 2022 would require data from 2014 through 2022) or do we need to indicate the years that we will be accessing the data (2023-2026)?

Answer 21: Refer to page 7 “Establish agreements for access to data sources.” Any such letter of support (LOS) or MOU/MOA should clearly articulate the planned activities, data to be shared with the applicant and ultimately what data will be provided to CDC. Specific dates or years are helpful, but not required.

Question 22: Is there a minimum expected effort for principal investigators? What does “actively involved” mean for this grant? Related to effort, are there salary caps to be aware of?

Answer 22: We expect the principal investigators to be familiar with the activities for which they have been funded to complete. The principal investigators should also actively participate in monthly calls that require their participation (individual site, All Sites, ADDM Studies, Education and Outreach, etc.). The salary cap is $203,700.

Question 23: We are working with the Memorandum of Understanding with the Department of Education for the RFA, where can we find the Appendix A with the specific data elements that are recommended to be collected from IDEA Part B?

Answer 23:  Appendix A is a document that describes the data elements that are collected in the ADDM program. This document is developed by each ADDM site and there is no specific required format. The data elements are described in general in the NOFO on page 8 and in more detail below. Page 8 states: “Qualified records are abstracted for the required ADDM Network data elements. These data elements include, but are not limited to, information from diagnostic or developmental assessments, evaluations to determine eligibility for special education services, ASD tests, individual education plans (IEPs), and intelligence quotient (IQ) and adaptive tests. Data are collected from birth through the current surveillance year and assembled into a single composite record for each child.”

Specific data elements include:

  • Demographics: name, address, date of birth, sex, race/ethnicity, address, guardian information.
  • Developmental evaluations: date, evaluation type, examiner specialty, diagnosis, non-ASD conditions, associated features.
  • ASD tests: informant, date, source, test name.
  • IQ and Adaptive tests: test name, source, date, domains, scores.
  • IEPs: school district, date, primary and secondary eligibilities, time spent in special education, autism classroom, type of services received.
  • IFSP: date, setting, services.
  • Other health and services: BMI, early intervention services, age at services.
  • IEPs (16-year-olds only): grade level, areas impacted by disability, needs, transition plan, education/training goals, employment goals, independent living goals, community living goals, course of study, exit date for special education, projected graduation year.
  • Other health and services (16-year-olds only): behavioral or seizure medication, suicidal or injurious behavior.

Question 24: We are considering applying for the “Enhancing Public Health Surveillance of Autism Spectrum Disorder” grant but have an eligibility question before moving forward. What constitutes a health vs educational context for the MOU requirement? We are working with ABA and SLP clinics, both of which have health and educational components, I would like to verify how to designate these clinics vis a vie health and education before applying. Any information would be fantastic.

Answer 24: Data sources are described on page 7 of the NOFO under “Establish agreements for access to data sources.”

  • Health Sources (e.g., physician offices and hospital networks) that provide diagnostic and developmental assessment information (required)
  • Education Sources (e.g., school districts or state department of education) that provide evaluations to determine eligibility for special education services under Part B of IDEA (e.g., psychological evaluations to determine special education eligibility, physical therapy and occupational therapy evaluations, and speech/language pathology assessments (required)
  • Early Intervention Sources that provide evaluations to determine eligibility for Early Intervention services under Part C of IDEA, or physical therapy and occupational therapy evaluations, and speech/language pathology assessments (encouraged, but not required)

Question 25: Can you please let me know if the reference section is expected to fall within the page limit for the narrative or if it may be added as an attachment?

Answer 25: Yes. The reference section is expected to fall within the page limit for the project narrative.

Question 26: I have a clarifying question about the language below. I’m trying to decide if this is a “new” requirement in this NOFO. We have had an MOU with our Health Department for the as long as we have been participating in ADDM. However, it does not use the specific language “bona fide” agent. The lack of this specific language hasn’t been a barrier to funding in the past but the language below suggests it might be a barrier for this NOFO.

(required) In order to gain access to health records, the recipient organization should have the ability to access personally identifiable health data under a Health Insurance and Portability and Accountability Act (HIPAA) exemption (e.g., be a state or local health department or be designated as a bona fide agent of the health department). Applicants must provide documentation that establishes this designation.

Answer 26: The MOU or letter of support does not need to include the term “bona fide agent”.  Please see page 24, “2. Additional Information on Eligibility.” The following list of documents are required in the application to be deemed responsive:

  • MOU/MOA with at least one health source or a letter of support indicating that the applicant will have access to personally identifiable health data.
  • MOU/MOA with at least one health educational source or letter of support indicating the applicant will have access to personally identifiable educational data.

If any of these required documents is missing, the application will be deemed non-responsive and will not be passed along for further review (e.g., Phase II-objective review panel).

Question 27: We are finishing our grant, and are being very attentive to the page limits (19) and the FAQs. A point of ambiguity remains with the appendices. We want to follow the rules, but have a well developed and highly detailed work plan and evaluation plan that fall beyond the 19 pages. We created condensed summaries for the narrative, but would like to a reference and include the expanded work plan and evaluation plan in the appendices (if the reviewer needs more info), but they are not on the approved appendices list. We do want to follow the rules, but do not want to leave out valuable information helpful to help the reviewers.

Answer 27: Please see page 29, “10. Project Narrative.”  Multi-component NOFOs may have a maximum of 15 pages for the “base” (subsections of the Project Description that the components share with each other, which may include target population, inclusion, collaboration, etc.); and up to 4 additional pages per component for Project Narrative subsections that are specific to each component.

Text should be single spaced, 12-point font, 1-inch margins, and number all pages.  Page limits include work plan; content beyond specified limits may not be reviewed.

Applicants should use federal plain language guidelines and Clear Communication Index to respond to this NOFO. Note that recipients should also use these tools when creating public communication materials supported by the NOFO. Failure to follow the guidance and format may negatively impact scoring of the application.

Please see page 52, “H. Other Information.” Following is a list of acceptable attachments applicants can upload as PDF files as part of their application at www.grants.gov. Applicants may not attach documents other than those listed; if other documents are attached, applications will not be reviewed.

  • Project Abstract
  • Project Narrative
  • Budget Narrative
  • Report on Programmatic, Budgetary, and Commitment Overlap
  • Table of Contents for Entire Submission

For international NOFOs:

  • SF424
  • SF424A
  • Funding Preference Deliverables

Attachments, as determined by CDC programs:

Resumes/CVs

Position descriptions

Letters of Support

Organization Charts

Non-profit organization IRS status forms, if applicable

Indirect Cost Rate, if applicable

Memorandum of Agreement (MOA)

Memorandum of Understanding (MOU)

Bona Fide Agent status documentation, if applicable

Question 28: I’m serving as PI but have 2 Grants.gov accounts. Are there any requirements for Grants.gov accounts that we should be aware of prior to submission, please let us know.

Answer 28: Please contact Grants.gov at 800-518-4726 for submission technical assistance.

Question 29: The NOFO indicates that applicants should include a DMP on page 17:

“Applicants must include a data management plan that includes, but is not limited to, the type of data that will be collected, procedures for collecting the data, how data will be stored, procedures for providing access to the data, provisions for maintaining data privacy, confidentiality, and data security.”

On page 18 the NOFO states “Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award

Can CDC clarify what information related to the DMP needs to be included in the application?

Answer 29: Please see page 17, “Data Management Plan.” Applicants must include a data management plan that includes, but is not limited to, the type of data that will be collected; procedures for collecting the data; how data will be stored; procedures for providing access to the data; and provisions for maintaining data privacy, confidentiality, and data security.

Award Information

Question 1: We are inquiring about the timeline for the funding opportunity of CDC-RFA-DD23-2301.

Answer 1:  The ADDM Network Notice of Funding Opportunity timeline:

  • Due date for Letter of Intent (recommended by not required): July 29, 2022
  • Due date for applications: September 9, 2022
  • Estimated award date: December 2, 2022
  • Anticipated budget/project start date: January 1, 2023

Budget

Question 1: The $600,000 ceiling is per year?

Answer 1: Yes, if a recipient is funded for both Component A and Component B.

Question 2: Is it allowable to get special permission to exceed the $450,000 total budget?

Answer 2: No. Refer to pages 22–23.

  1. Approximate Average Award:
    $450,000 per budget period
    Average award if funded only for Component A: $450,000
    Average award if funded for Component A and Component B: $600,000
  2. Award Ceiling:
    $600,000 per budget period
    The amount is subject to availability of funds.
    Ceiling for Component A: $450,000
    Ceiling for Component B: $150,000
  3. Award Floor:
    $400,000 per budget period
    The amount is subject to the availability of funds.
    Floor for Component A: $400,000
    Floor for Component B: $125,000

Question 3: Carry forwards are generally not allowed with a competitive renewal, but perhaps an exception can be made?  If we do get the award we could use carry forward funds (if we have any left) to help. IF we don’t get the award we can perhaps return any remaining funds?

Answer 3: Applicants cannot use current funding (e.g., carry forwards) to offset the budget for the new application.

Eligibility

Question 1: Since my jurisdiction is also within California, will that be a problem since San Diego is also a site?

Answer 1: This NOFO is an open competition. Current and previous ADDM Network sites must apply if they wish to be considered for funding. To ensure maximum coverage across the United States, no more than one application per state will be funded. If multiple applicants from the same state apply under this NOFO, only the highest-scoring applicant from that state will be selected for funding. Applicants from the same state who are interested in applying could consider collaborating.

Question 2: Can we provide state mandates that would show we (as the public health department) have legal authority to access medical information for autism?

Answer 2: Yes.

Letter of Intent

Question 1: If you receive multiple LOIs from one state, will you facilitate collaboration among potential applicants from the same state?

Answer 1: No. CDC will not facilitate collaboration among potential applicants from the same state. Refer to page 42. To ensure maximum U.S. coverage, no more than one application per state will be funded. If multiple applicants from the same state apply under this NOFO only the highest scoring applicant from that state will be selected for funding.